Process for manufacturing tablets by using a fluent and settable matrix, and tablets obtained therewith

Details for Australian Patent Application No. 2010284028 (hide)

Owner WAXTABS (PTY) LTD

Inventors Liebenberg, Poon; Wiid, Thomas

Agent Griffith Hack

Pub. Number AU-A-2010284028

PCT Pub. Number WO2011/022737

Priority 2010/02780 20.04.10 ZA; 2009/05684 17.08.09 ZA; 2009/08736 08.12.09 ZA

Filing date 16 August 2010

Wipo publication date 24 February 2011

International Classifications

A61K 9/20 (2006.01) Medicinal preparations characterised by special physical form - Pills, lozenges or tablets

A61K 47/06 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - Organic compounds

A61K 47/14 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - Esters of carboxylic acids

A61K 47/30 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - Macromolecular compounds

A61K 47/44 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - Oils, fats or waxes according to more than one of groups

Event Publications

29 March 2012 PCT application entered the National Phase

  PCT publication WO2011/022737 Priority application(s): WO2011/022737

19 April 2012 Amendment Made

  The nature of the amendment is as shown in the statement(s) filed 01 Mar 2012

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2010284036-Catalytic domains from lysyl oxidase and LOXL2

2010284018-Antibodies against the ectodomain of ErbB3 and uses thereof